{"id":"W2596486877","doi":"10.1200/jco.2004.22.90140.630","title":"A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Metastatic breast cancer; Anthracycline; Trastuzumab; Ejection fraction; Cardiotoxicity; Doxorubicin; Internal medicine; Breast cancer; Cancer; Heart failure; Oncology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00110251,0.0001850027,0.001880047,0.0002026445,0.00003978133,0.000005319939,0.00009183212,0.0002514533,0.0003377685],"category_scores_gemma":[0.0003753336,0.0001340564,0.0003513392,0.0001909553,0.0002526641,0.0001299005,0.00004502938,0.0008000253,0.000001122727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000379639,"about_ca_system_score_gemma":0.002233856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004384693,"about_ca_topic_score_gemma":0.0006298968,"domain_scores_codex":[0.9965832,0.0003786921,0.002287429,0.000217341,0.0002551659,0.0002781708],"domain_scores_gemma":[0.9970823,0.0007838467,0.001498017,0.0001029328,0.000199227,0.0003336952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5181255,0.1032228,0.02191431,0.0001641496,0.002283253,0.003680516,0.002328792,0.0002531408,0.0508188,0.00002169203,0.0007614227,0.2964257],"study_design_scores_gemma":[0.8672624,0.06480657,0.05905369,0.0005383471,0.002188121,0.0009337235,0.000259558,0.000355308,0.001571196,0.0001065575,0.002752598,0.0001719372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99044,0.001255296,0.00003178978,0.006603307,0.001095828,0.0004468197,0.00002904928,0.000006406336,0.00009152367],"genre_scores_gemma":[0.9950308,0.0011782,0.002242773,0.0006525,0.0007700377,0.000006375863,0.000003353115,0.00001758374,0.0000983928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3491369,"threshold_uncertainty_score":0.5466662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1422473115020502,"score_gpt":0.5265052184546788,"score_spread":0.3842579069526286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}